Search
Alnylam Pharmaceuticals Inc
ALNYAdd to Watchlist
278.090USD
-4.630-1.64%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
37.13BMarket Cap
68.06P/E TTM
Alnylam Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Alnylam Pharmaceuticals Inc is 7.42, ranking 127 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 68.06, which is 2041.36% below the recent high of 1457.49 and 851.78% above the recent low of -511.69.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
